Follow us on LinkedIn. Cambridge Molecular Diagnostics Limited (SwiftDx) announces the launch of a new lateral flow test for the detection of Mycoplasma contamination. The innovative, easy-to-use, rapid test uses an adapted PCR method and provides accurate results within minutes, making it a valuable tool for laboratories and manufacturers in academia and the biotech and pharmaceutical industries. The test has been fully validated, including evaluation within the University of Cambridge. … Continue reading →